RSNA 2026 will spotlight advances in CT imaging, featuring photon-counting CT, deep learning image reconstruction, and emerging applications that enhance resolution, lower dose, and add quantitative value to diagnostics.
Key Details
- 1Photon-counting CT (PCCT) enables ultra-high-resolution, low-dose scans and is moving into broader clinical use beyond top centers.
- 2Deep-learning image reconstruction allows dose and contrast reduction while improving or maintaining diagnostic image quality.
- 3AI-driven quantitative CT supports opportunistic biomarker extraction (e.g., coronary calcium, bone density) from routine imaging.
- 4Highlights include research on lowering radiation, CT-based risk stratification for lung cancer, AI-enabled body composition analysis, and impacts of air pollution on lung function.
- 5Studies will demonstrate PCCT's clinical value for various patient populations, including those with interstitial lung disease and high BMI.
- 6Sessions will address practical CT challenges like emergency imaging, forensic/post-mortem CT, and reducing CT's environmental impact.
Why It Matters
Photon-counting CT and deep-learning advances represent major technological leaps, with real-world applications poised to improve diagnostic accuracy, reduce harm, and deliver new quantitative data from ordinary scans. Showcasing these innovations at RSNA signals accelerating clinical integration and highlights emerging opportunities for radiology AI in routine care.

Source
AuntMinnie
Related News

•AuntMinnie
LLM-Based Chart Summarization Tool Reduces Radiologist Review Time
An LLM-based chart summarization tool safely reduced radiologist study review time by 17%.

•Radiology Business
FDA Approves AI Software for Brain Aneurysm Detection on CTA
FDA cleared Uptunity, an AI software, to aid radiologists in detecting brain aneurysms on CT angiography.

•AuntMinnie
SIIM-CAIMI Showcases Advances and Future Trends in Radiology AI
SIIM-CAIMI 2024 explored the future of radiology AI, emphasizing multidisciplinary collaboration and novel research.